Form 4 for CUE Cue Biopharma, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-30 · accession 0001193125-26-000900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-02 | 2025-12-30 | CUE | Sarraf Pasha | Dir | P - Purchase | $0.3079 | +323.9K | 246.4K | New | +$99.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-30 | P | A | 77,417 | $0.3 | 323,857 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-30 | P | A | 86,947 | $0.32 | 168,324 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-30 | P | A | 77,148 | $0.3 | 81,377 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-30 | P | A | 4,229 | $0.31 | 4,229 | D | — | — | |
| 5 | Common | Common Stock | 2025-12-30 | P | A | 78,116 | $0.31 | 246,440 | D | — | — |